Millennium Management LLC Sells 674,722 Shares of Perrigo Company plc (NYSE:PRGO)

Millennium Management LLC decreased its holdings in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 94.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 38,743 shares of the company's stock after selling 674,722 shares during the quarter. Millennium Management LLC's holdings in Perrigo were worth $996,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. Headlands Technologies LLC lifted its holdings in Perrigo by 1,942.0% during the 4th quarter. Headlands Technologies LLC now owns 1,409 shares of the company's stock worth $36,000 after purchasing an additional 1,340 shares in the last quarter. Venturi Wealth Management LLC boosted its position in shares of Perrigo by 97.8% in the fourth quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company's stock valued at $108,000 after acquiring an additional 2,084 shares during the period. Mirae Asset Global Investments Co. Ltd. bought a new stake in Perrigo during the 4th quarter worth approximately $149,000. Sterling Capital Management LLC lifted its stake in Perrigo by 51.8% in the 4th quarter. Sterling Capital Management LLC now owns 8,144 shares of the company's stock worth $209,000 after purchasing an additional 2,780 shares in the last quarter. Finally, Parvin Asset Management LLC purchased a new position in shares of Perrigo during the 4th quarter valued at $212,000. 95.91% of the stock is owned by institutional investors.

Perrigo Stock Up 0.2%

NYSE:PRGO traded up $0.06 during trading hours on Monday, reaching $26.22. 1,070,039 shares of the company traded hands, compared to its average volume of 1,488,234. The business's 50-day moving average price is $25.96 and its two-hundred day moving average price is $26.16. The stock has a market capitalization of $3.60 billion, a P/E ratio of -22.41 and a beta of 0.46. Perrigo Company plc has a 1 year low of $23.14 and a 1 year high of $30.93. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94.

Perrigo (NYSE:PRGO - Get Free Report) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.04. The business had revenue of $1.04 billion for the quarter, compared to the consensus estimate of $1.09 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The company's revenue for the quarter was down 3.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.29 earnings per share. Analysts predict that Perrigo Company plc will post 2.56 earnings per share for the current year.

Perrigo Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Friday, May 30th will be paid a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a yield of 4.42%. The ex-dividend date is Friday, May 30th. Perrigo's dividend payout ratio (DPR) is presently -88.55%.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Perrigo from a "hold" rating to a "buy" rating in a research report on Saturday, May 24th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $33.00.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.